Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Naoumov NV, Lopes AR, Burra P, Caccamo L, Iemmolo RM, de Man RA, Bassendine M, O'Grady JG, Portmann BC, Anschuetz G, Barrett CA, Williams R, Atkins M. Naoumov NV, et al. Among authors: anschuetz g. J Hepatol. 2001 Jun;34(6):888-94. doi: 10.1016/s0168-8278(01)00039-3. J Hepatol. 2001. PMID: 11451173 Clinical Trial.
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.
Perrillo RP, Wright T, Rakela J, Levy G, Schiff E, Gish R, Martin P, Dienstag J, Adams P, Dickson R, Anschuetz G, Bell S, Condreay L, Brown N; Lamivudine North American Transplant Group. Perrillo RP, et al. Among authors: anschuetz g. Hepatology. 2001 Feb;33(2):424-32. doi: 10.1053/jhep.2001.21554. Hepatology. 2001. PMID: 11172345 Clinical Trial.
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
Hann HW, Fontana RJ, Wright T, Everson G, Baker A, Schiff ER, Riely C, Anschuetz G, Gardner SD, Brown N, Griffiths D; United States Lamivudine Compassionate Use Study Group. Hann HW, et al. Among authors: anschuetz g. Liver Transpl. 2003 Jan;9(1):49-56. doi: 10.1053/jlts.2003.50005. Liver Transpl. 2003. PMID: 12514773 Free article.
ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.
Gibson CM, Chi G, Duffy D, Bahit MC, White H, Korjian S, Alexander JH, Lincoff AM, Anschuetz G, Girgis IG, Nicolau JC, Lopes RD, Cornel JH, Bainey KR, Libby P, Sacks FM, Ridker PM, Goodman SG, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA; AEGIS-II Committees and Investigators. Gibson CM, et al. Among authors: anschuetz g. J Am Coll Cardiol. 2024 Nov 26;84(22):2185-2192. doi: 10.1016/j.jacc.2024.08.001. Epub 2024 Sep 2. J Am Coll Cardiol. 2024. PMID: 39230545 Clinical Trial.
Giving Credit Where Credit Is Due-Thank You, DIS!
Anschuetz G. Anschuetz G. Sex Transm Dis. 2024 Sep 1;51(9):591-592. doi: 10.1097/OLQ.0000000000002039. Sex Transm Dis. 2024. PMID: 39150121 No abstract available.
COVID-19 Case Investigation and Contact Tracing in the US, 2020.
Lash RR, Moonan PK, Byers BL, Bonacci RA, Bonner KE, Donahue M, Donovan CV, Grome HN, Janssen JM, Magleby R, McLaughlin HP, Miller JS, Pratt CQ, Steinberg J, Varela K, Anschuetz GL, Cieslak PR, Fialkowski V, Fleischauer AT, Goddard C, Johnson SJ, Morris M, Moses J, Newman A, Prinzing L, Sulka AC, Va P, Willis M, Oeltmann JE; COVID-19 Contact Tracing Assessment Team. Lash RR, et al. Among authors: anschuetz gl. JAMA Netw Open. 2021 Jun 1;4(6):e2115850. doi: 10.1001/jamanetworkopen.2021.15850. JAMA Netw Open. 2021. PMID: 34081135 Free PMC article.
26 results